{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:58:06Z","timestamp":1787731086500,"version":"build-2784847793"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["AC20\/00077"],"award-info":[{"award-number":["AC20\/00077"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["A2023012F"],"award-info":[{"award-number":["A2023012F"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["AC20\/00077"],"award-info":[{"award-number":["AC20\/00077"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["JPND2020-568-025"],"award-info":[{"award-number":["JPND2020-568-025"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["JDC2022-048922-I"],"award-info":[{"award-number":["JDC2022-048922-I"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Cell Biology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ceb.2025.102528","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T08:21:05Z","timestamp":1746778865000},"page":"102528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Alzheimer's disease and vascular biology \u2013 A focus on the procoagulant state"],"prefix":"10.1016","volume":"95","author":[{"given":"Marta","family":"Casquero-Veiga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Ceron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8802-4338","authenticated-orcid":false,"given":"Marta","family":"Cortes-Canteli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ceb.2025.102528_bib1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer's disease continuum","volume":"19","author":"Gustavsson","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ceb.2025.102528_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"Deture","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.ceb.2025.102528_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines7040097","article-title":"Reasons for failed trials of disease-modifying treatments for alzheimer disease and their contribution in recent research","volume":"7","author":"Yiannopoulou","year":"2019","journal-title":"Biomedicines"},{"key":"10.1016\/j.ceb.2025.102528_bib4","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacc.2019.10.062","article-title":"Alzheimer's disease and vascular aging","volume":"75","author":"Cortes-Canteli","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ceb.2025.102528_bib5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neurobiolaging.2014.10.030","article-title":"Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration","volume":"36","author":"Cortes-Canteli","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ceb.2025.102528_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrn.2018.13","article-title":"Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics","volume":"19","author":"Petersen","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.ceb.2025.102528_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.neuron.2010.05.014","article-title":"Fibrinogen and \u03b2-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to alzheimer's disease","volume":"66","author":"Cortes-Canteli","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ceb.2025.102528_bib8","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.jacc.2019.07.081","article-title":"Long-term dabigatran treatment delays Alzheimer's disease pathogenesis in the TgCRND8 mouse model","volume":"74","author":"Cortes-Canteli","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ceb.2025.102528_bib9","article-title":"Oral anticoagulants: a plausible new treatment for Alzheimer's disease?","author":"Toribio-Fernandez","year":"2023","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ceb.2025.102528_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3233\/JAD-2012-120820","article-title":"Fibrinogen and altered hemostasis in Alzheimer's disease","volume":"32","author":"Cortes-Canteli","year":"2012","journal-title":"J Alzheim Dis"},{"key":"10.1016\/j.ceb.2025.102528_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114683","article-title":"Potential links between platelets and amyloid-\u03b2 in the pathogenesis of Alzheimer's disease: evidence from in vitro, in vivo, and clinical studies","volume":"374","author":"Yubolphan","year":"2024","journal-title":"Exp Neurol"},{"key":"10.1016\/j.ceb.2025.102528_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00747","article-title":"Platelets in neurodegenerative conditions\u2014friend or foe?","volume":"11","author":"Leiter","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ceb.2025.102528_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101695","article-title":"Platelets: the missing link between the blood and brain?","volume":"183","author":"Leiter","year":"2019","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.ceb.2025.102528_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126292","article-title":"Platelets and neurodegenerative diseases: current knowledge and future perspectives","volume":"25","author":"Gallo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ceb.2025.102528_bib15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.2022015970","article-title":"The multifaceted role of platelets in mediating brain function","volume":"140","author":"Burnouf","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ceb.2025.102528_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120855","article-title":"Redefining oxidative stress in Alzheimer's disease: targeting platelet reactive oxygen species for novel therapeutic options","volume":"306","author":"Beura","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.ceb.2025.102528_bib17","doi-asserted-by":"crossref","DOI":"10.36922\/an.3799","article-title":"Unraveling the thrombin\u2013Alzheimer\u2019s connection: oral anticoagulants as potential neuroprotective therapeutics","volume":"3","author":"Grossmann","year":"2024","journal-title":"Adv Neurol"},{"key":"10.1016\/j.ceb.2025.102528_bib18","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/j.jtha.2023.08.014","article-title":"Fibrinogen and fibrin: synthesis, structure, and function in health and disease","volume":"21","author":"Wolberg","year":"2023","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.ceb.2025.102528_bib19","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.3390\/ijms24087046","article-title":"Vascular dysfunction in alzheimer's disease: alterations in the plasma contact and fibrinolytic systems","volume":"24","author":"Badimon","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ceb.2025.102528_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.625844","article-title":"The correlations between plasma fibrinogen with amyloid-beta and tau levels in patients with Alzheimer's disease","volume":"14","author":"Fan","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.ceb.2025.102528_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1361772","article-title":"Association of multiple metabolic and cardiovascular markers with the risk of cognitive decline and mortality in adults with Alzheimer's disease and AD-related dementia or cognitive decline: a prospective cohort study","volume":"16","author":"Liu","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.ceb.2025.102528_bib22","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1080\/00207454.2020.1860038","article-title":"Fibrinogen isoforms as potential blood-based biomarkers of Alzheimer's disease using a proteomics approach","volume":"132","author":"Rehiman","year":"2022","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.ceb.2025.102528_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/01616412.2017.1281195","article-title":"Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease","volume":"39","author":"Kitamura","year":"2017","journal-title":"Neurol Res"},{"key":"10.1016\/j.ceb.2025.102528_bib24","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3233\/JAD-141266","article-title":"Plasma protein profiling of mild cognitive impairment and alzheimer's disease across two independent cohorts","volume":"43","author":"Muenchhoff","year":"2014","journal-title":"J Alzheim Dis"},{"key":"10.1016\/j.ceb.2025.102528_bib25","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.neuron.2019.01.014","article-title":"Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an alzheimer's disease model","volume":"101","author":"Merlini","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.ceb.2025.102528_sref26","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/s41590-023-01522-0","article-title":"Defining blood-induced microglia functions in neurodegeneration through multiomic profiling","volume":"24","author":"Mendiola","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ceb.2025.102528_sref27","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1093\/brain\/awac236","article-title":"Activation of Wnt\/\u03b2-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease","volume":"145","author":"Wang","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.ceb.2025.102528_bib28","doi-asserted-by":"crossref","first-page":"21812","DOI":"10.1073\/pnas.1010373107","article-title":"Alzheimer's disease peptide \u03b2-amyloid interacts with fibrinogen and induces its oligomerization","volume":"107","author":"Ahn","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ceb.2025.102528_bib29","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood-2016-03-705228","article-title":"Biochemical and structural analysis of the interaction between \u03b2-amyloid and fibrinogen","volume":"128","author":"Zamolodchikov","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ceb.2025.102528_bib30","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1182\/blood-2011-11-389668","article-title":"A\u03b2 delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin","volume":"119","author":"Zamolodchikov","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ceb.2025.102528_bib31","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1084\/jem.20131751","article-title":"A novel A\u03b2-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice","volume":"211","author":"Ahn","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.ceb.2025.102528_bib32","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacc.2019.10.062","article-title":"Alzheimer's disease and vascular aging: JACC focus seminar","volume":"75","author":"Cortes-Canteli","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ceb.2025.102528_bib33","unstructured":"Cajamarca SA, Norris EH, van der Weerd L, Strickland S, Jin Ahn H, Rosenwald J: Cerebral amyloid angiopathy-linked \u03b2-amyloid mutations promote cerebral fibrin deposits via increased binding affinity for fibrinogen. [date unknown], doi:10.1073\/pnas.1921327117\/-\/DCSupplemental."},{"key":"10.1016\/j.ceb.2025.102528_sref34","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314450121","article-title":"Lecanemab blocks the effects of the A\u03b2\/fibrinogen complex on blood clots and synapse toxicity in organotypic culture","volume":"121","author":"Singh","year":"2024","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ceb.2025.102528_bib35","series-title":"Platelets in thrombotic and non-thrombotic disorders: pathophysiology, pharmacology and therapeutics: an update","first-page":"513","article-title":"Platelets in neurological disorders","author":"Canobbio","year":"2017"},{"key":"10.1016\/j.ceb.2025.102528_bib36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/bbrc.1995.2103","article-title":"Platelets are the primary source of amyloid \u03b2-peptide in human blood","volume":"213","author":"Chen","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ceb.2025.102528_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.571083","article-title":"On the role of platelet-generated amyloid beta peptides in certain amyloidosis health complications","volume":"11","author":"Inyushin","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ceb.2025.102528_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainresbull.2016.11.008","article-title":"Platelets are responsible for the accumulation of \u03b2-amyloid in blood clots inside and around blood vessels in mouse brain after thrombosis","volume":"128","author":"Kucheryavykh","year":"2017","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.ceb.2025.102528_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00065","article-title":"Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease","volume":"9","author":"Canobbio","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.ceb.2025.102528_bib40","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/jcbfm.2010.140","article-title":"Predictive value of platelet activation for the rate of cognitive decline in Alzheimers disease patients","volume":"30","author":"Stellos","year":"2010","journal-title":"J Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.ceb.2025.102528_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090523","article-title":"Blood platelets in the progression of alzheimer's disease","volume":"9","author":"Gowert","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ceb.2025.102528_bib42","doi-asserted-by":"crossref","first-page":"630","DOI":"10.18632\/aging.204502","article-title":"Immune-mediated platelet depletion augments Alzheimer's disease neuropathological hallmarks in APP-PS1 mice","volume":"15","author":"de Sousa","year":"2023","journal-title":"Aging"},{"key":"10.1016\/j.ceb.2025.102528_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ceb.2025.102528_bib44","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/med.21965","article-title":"Antiplatelet drugs: potential therapeutic options for the management of neurodegenerative diseases","volume":"43","author":"Beura","year":"2023","journal-title":"Med Res Rev"},{"key":"10.1016\/j.ceb.2025.102528_bib45","article-title":"Platelets contribute to amyloid-b aggregation in cerebral vessels through integrin a IIb b 3-induced outside-in signaling and clusterin release","volume":"429","author":"Donner","year":"2016","journal-title":"Sci Signal"},{"key":"10.1016\/j.ceb.2025.102528_bib46","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-022-04397-w","article-title":"Can the administration of platelet lysates to the brain help treat neurological disorders?","volume":"79","author":"Nebie","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ceb.2025.102528_sref47","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100154","article-title":"Human platelets release amyloid peptides \u03b21-40 and \u03b21-42 in response to hemostatic, immune, and hypoxic stimuli","volume":"7","author":"Wolska","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.ceb.2025.102528_bib48","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bbb\/zbab201","article-title":"Amyloid \u03b2 protein negatively regulates human platelet activation induced by thrombin receptor-activating protein","volume":"86","author":"Mizutani","year":"2022","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.ceb.2025.102528_bib49","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1160\/TH17-03-0219","article-title":"Protease-activated receptor PAR-4: an inducible switch between thrombosis and vascular inflammation?","volume":"117","author":"Fender","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ceb.2025.102528_sref50","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2024.103952","article-title":"Reduced platelet activation and thrombus formation in male transgenic model mice of Alzheimer's disease suggests early sex-specific differences in platelet pathophysiology","volume":"130","author":"Donner","year":"2024","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.ceb.2025.102528_bib51","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.cellsig.2014.05.019","article-title":"Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer's disease","volume":"26","author":"Jarre","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.ceb.2025.102528_sref52","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023918","article-title":"Platelet function is associated with dementia risk in the Framingham Heart study","volume":"11","author":"Ramos-Cejudo","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ceb.2025.102528_bib53","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3233\/JAD-215533","article-title":"Cross-sectional association between blood cell phenotypes, cognitive function, and brain imaging measures in the community-based Framingham Heart study","volume":"87","author":"Fang","year":"2022","journal-title":"J Alzheim Dis"},{"key":"10.1016\/j.ceb.2025.102528_sref54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neurobiolaging.2022.06.004","article-title":"Relationships between diabetes-related vascular risk factors and neurodegeneration biomarkers in healthy aging and Alzheimer's disease","volume":"118","author":"Palix","year":"2022","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ceb.2025.102528_bib55","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3906\/sag-1212-5","article-title":"The increase of mean platelet volume in patients with Alzheimer disease","volume":"44","author":"Ko\u00e7","year":"2014","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.ceb.2025.102528_bib56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.archger.2011.09.016","article-title":"Increased mean platelet volume (MPV) indicating the vascular risk in Alzheimer's disease (AD)","volume":"55","author":"Yesil","year":"2012","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.ceb.2025.102528_bib57","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/09537104.2013.831064","article-title":"Mean platelet volume and platelet distribution width in vascular dementia and Alzheimer's disease","volume":"25","author":"Liang","year":"2014","journal-title":"Platelets"},{"key":"10.1016\/j.ceb.2025.102528_bib58","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jpsychires.2013.01.014","article-title":"Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease","volume":"47","author":"Wang","year":"2013","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.ceb.2025.102528_bib59","article-title":"Association of peripheral blood cell profile with alzheimer's disease: a meta-analysis","volume":"14","author":"Huang","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.ceb.2025.102528_sref60","article-title":"Integrated analyses of brain and platelet omics reveal their common altered and driven molecules in Alzheimer's disease","volume":"3","author":"Yu","year":"2022","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.ceb.2025.102528_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1196083","article-title":"The platelet transcriptome and proteome in Alzheimer's disease and aging: an exploratory cross-sectional study","volume":"10","author":"de Sousa","year":"2023","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.ceb.2025.102528_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-023-03099-5","article-title":"Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease","volume":"23","author":"Fu","year":"2023","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ceb.2025.102528_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/640723","article-title":"Dabigatran, rivaroxaban, or apixaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of subgroups","volume":"2013","author":"G\u00f3mez-Outes","year":"2013","journal-title":"Thrombosis"},{"key":"10.1016\/j.ceb.2025.102528_bib64","article-title":"Short-term treatment with dabigatran alters protein expression patterns in a late-stage tau-based Alzheimer's disease mouse model","volume":"24","author":"Iannucci","year":"2020","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.ceb.2025.102528_bib65","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/JAD-215318","article-title":"Protective effect of rivaroxaban against amyloid pathology and neuroinflammation through inhibiting PAR-1 and PAR-2 in alzheimer's disease mice","volume":"86","author":"Bian","year":"2022","journal-title":"J Alzheim Dis"},{"key":"10.1016\/j.ceb.2025.102528_bib66","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.nbd.2010.06.008","article-title":"Enoxaparin treatment administered at both early and late stages of amyloid \u03b2 deposition improves cognition of APPswe\/PS1dE9 mice with differential effects on brain A\u03b2 levels","volume":"40","author":"Timmer","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ceb.2025.102528_bib67","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.0550-04.2004","article-title":"Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and \u03b2-amyloid accumulation in a mouse model of alzheimer's disease","volume":"24","author":"Bergamaschini","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.ceb.2025.102528_bib68","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/a-1384-3715","article-title":"Factor XI as a target for new anticoagulants","volume":"41","author":"Fredenburgh","year":"2021","journal-title":"H\u00e4mostaseologie"},{"key":"10.1016\/j.ceb.2025.102528_bib69","doi-asserted-by":"crossref","first-page":"647","DOI":"10.14283\/jpad.2023.105","article-title":"Fibrin-targeting immunotherapy for dementia","volume":"10","author":"Kantor","year":"2023","journal-title":"J Prevent Alzheimer\u2019s Dis"},{"key":"10.1016\/j.ceb.2025.102528_bib70","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","article-title":"Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ceb.2025.102528_bib71","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/med.21965","article-title":"Antiplatelet drugs: potential therapeutic options for the management of neurodegenerative diseases","volume":"43","author":"Beura","year":"2023","journal-title":"Med Res Rev"},{"key":"10.1016\/j.ceb.2025.102528_bib72","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1802021115","article-title":"Aspirin binds to PPAR\u03b1 to stimulate hippocampal plasticity and protect memory","volume":"115","author":"Patel","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ceb.2025.102528_bib73","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1523\/JNEUROSCI.0054-18.2018","article-title":"Aspirin induces lysosomal biogenesis and attenuates amyloid plaque pathology in a mouse model of alzheimer's disease via PPAR\u03b1","volume":"38","author":"Chandra","year":"2018","journal-title":"J Neurosci"},{"key":"10.1016\/j.ceb.2025.102528_bib74","doi-asserted-by":"crossref","first-page":"197.e21","DOI":"10.1016\/j.neurobiolaging.2010.06.014","article-title":"Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease","volume":"33","author":"Wilkinson","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ceb.2025.102528_bib75","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.brainres.2008.01.095","article-title":"Ibuprofen reduces A\u03b2, hyperphosphorylated tau and memory deficits in Alzheimer mice","volume":"1207","author":"McKee","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.ceb.2025.102528_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172956","article-title":"Clopidogrel combats neuroinflammation and enhances learning behavior and memory in a rat model of Alzheimer's disease","volume":"195","author":"Khalaf","year":"2020","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.ceb.2025.102528_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.788407","article-title":"Anti-platelet therapy is associated with lower risk of dementia in patients with cerebral small vessel disease","volume":"14","author":"Pan","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.ceb.2025.102528_bib78","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00213-021-05798-8","article-title":"Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases","volume":"238","author":"Zare","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ceb.2025.102528_bib79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/exnr.1999.7055","article-title":"Inhibition of alzheimer's \u03b2-amyloid induced vasoactivity and proinflammatory response in microglia by a cGMP-dependent mechanism","volume":"157","author":"Paris","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.ceb.2025.102528_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00559","article-title":"Pharmacological potential of cilostazol for alzheimer's disease","volume":"10","author":"Ono","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ceb.2025.102528_bib81","article-title":"Cilostazol modulates autophagic degradation of \u03b2-amyloid peptide via SIRT1-coupled LKB1\/AMPK\u03b1 signaling in neuronal cells","volume":"11","author":"Park","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ceb.2025.102528_bib82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2018.04.032","article-title":"Supratherapeutic concentrations of cilostazol inhibits \u03b2-amyloid oligomerization in vitro","volume":"677","author":"Shozawa","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.ceb.2025.102528_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.805169","article-title":"Crosstalk between the NLRP3 inflammasome\/ASC speck and amyloid protein aggregates drives disease progression in alzheimer's and Parkinson's disease","volume":"15","author":"Hulse","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.ceb.2025.102528_bib84","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1525466113","article-title":"The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function","volume":"113","author":"Marsh","year":"2016","journal-title":"Proc Natl Acad Sci"}],"container-title":["Current Opinion in Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955067425000663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955067425000663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:22:00Z","timestamp":1778214120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955067425000663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":84,"alternative-id":["S0955067425000663"],"URL":"https:\/\/doi.org\/10.1016\/j.ceb.2025.102528","relation":{},"ISSN":["0955-0674"],"issn-type":[{"value":"0955-0674","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alzheimer's disease and vascular biology \u2013 A focus on the procoagulant state","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ceb.2025.102528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102528"}}